Genprex, Inc.
GNPXOther · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | — | $0 | $0 | $0 | $0 | $0 |
| Operating income | −$15.5M | −$21.2M | −$31.1M | −$23.8M | −$5.3M | −$18.0M |
| Net income | −$16.2M | −$21.1M | −$30.9M | −$23.7M | −$5.3M | −$17.9M |
| Total assets | $10.2M | $4.1M | $10.7M | $25.1M | $42.9M | $31.4M |
| Total liabilities | $2.2M | $2.5M | — | $2.4M | $1.6M | — |
| Equity | $8.0M | $1.6M | $7.4M | $22.3M | $41.3M | $30.9M |
| EPS (diluted) | $-17.40 | $-266.89 | $-22.56 | $-19.80 | $-0.11 | — |
| Shares out. | 24.2M | 1.9M | 52.0M | 47.9M | 43.3M | 32.8M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- —
- Net margin
- —
- Return on equity
- −203.8%
- Return on assets
- −159.7%
- Return on capital (ROCE)
- −194.3%
- Liabilities / assets
- 21.6%
- Debt / equity
- 0.28×
- Book value / share
- $0.33
- Revenue growth (YoY)
- —
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- -57.35distress
- Accruals / assets
- −9.0%clean
- Piotroski F-Score
- 4/7mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 2 severe● 1 warning● 2 good- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Negative operating cash flow
- Conservative leverage (liabilities < 50% of assets)
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Kmissed a reporting deadline ↗Apr 1, 2025
- NT 10-Qmissed a reporting deadline ↗Aug 15, 2023
- NT 10-Qmissed a reporting deadline ↗May 16, 2023
- NT 10-Qmissed a reporting deadline ↗May 16, 2019
- NT 10-Kmissed a reporting deadline ↗Apr 3, 2018
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Longnecker Brent MDirector | Apr 14, 2026 | Sell | 8 | $1.23 |
| Berger Mark StanleyOfficer — Chief Medical Officer | Feb 27, 2026 | Tax withholding | 7,168 | $2.00 |
| Confer Ryan M.Officer — President, CEO and CFO | Feb 27, 2026 | Tax withholding | 9,330 | $2.00 |
| Moreno Toscano Jose AntonioDirector | Dec 22, 2025 | Grant | 9,000 | $0.00 |
| Berger Mark StanleyOfficer — Chief Medical Officer | Dec 22, 2025 | Grant | 28,500 | $0.00 |
| Confer Ryan M.Officer — President, CEO and CFO | Dec 22, 2025 | Grant | 45,000 | $0.00 |
| Longnecker Brent MDirector | Dec 22, 2025 | Grant | 9,000 | $0.00 |
| Wilson William R Jr.Director | Dec 22, 2025 | Grant | 9,000 | $0.00 |
| Berger Mark StanleyOfficer — Chief Medical Officer | Jun 30, 2025 | Tax withholding | 4,500 | $0.23 |
| Confer Ryan M.Officer — President, CEO and CFO | Jun 30, 2025 | Tax withholding | 5,775 | $0.23 |
| Berger Mark StanleyOfficer — Chief Medical Officer | Feb 18, 2025 | Tax withholding | 585 | $0.41 |
| Confer Ryan M.Officer — President, CEO and CFO | Feb 18, 2025 | Tax withholding | 395 | $0.41 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 1.0M | 2.9 | -7.7% |
| Apr 30, 2026 | 1.1M | 1.0 | +121.9% |
| Apr 15, 2026 | 505,519 | 1.1 | +31.0% |
| Mar 31, 2026 | 385,859 | 1.4 | -19.6% |
| Mar 13, 2026 | 479,992 | 1.2 | -32.4% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Other material eventMay 26, 2026
- Other material eventMay 14, 2026
- Other material eventApr 30, 2026
- Other material eventApr 28, 2026
- Regulation FD disclosure · Other material eventApr 21, 2026
- Other material eventMar 18, 2026
- Other material eventFeb 23, 2026
- Other material eventFeb 10, 2026
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 8-KFORM 8-KMay 26, 2026
- 8-KFORM 8-KMay 14, 2026
- 10-QFORM 10-QMay 13, 2026
- SCHEDULE 13G/AMay 11, 2026
- 8-KFORM 8-KApr 30, 2026
- ARSFORM ARSApr 29, 2026
- DEF 14AFORM DEF 14AApr 29, 2026
- 8-KFORM 8-KApr 28, 2026
- 8-KFORM 8-KApr 21, 2026
- PRE 14AFORM PRE 14AApr 17, 2026
- 4FORM 4Apr 15, 2026
- 10-KFORM 10-KMar 30, 2026
- 8-KFORM 8-KMar 18, 2026
- 4FORM 4Feb 27, 2026
- 4FORM 4Feb 27, 2026
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.